Inhalation & nasal development and manufacturing services
Recipharm offers a range of inhalation manufacturing and development capabilities for novel respiratory products.
Our facilities include:
- Commercial manufacturing capabilities for pMDI and nasal spray
- DPI manufacturing suite, ready for customer’s bespoke equipment
- Pilot plant, including small scale pMDI manufacture (directly scaleable to commercial manufacturing)
- Seven clinical and development suites with dedicated team of scientists and engineers
- State-of-the-art quality control laboratories
- Extensive suite of ICH stability cabinets In house microbiology laboratory
Recipharm Inhalation Solutions™ offers an end-to-end service for inhalation drug products and devices spanning early stage development to commercial manufacture.
Learn more about our capabilities by downloading our fact sheet below.